Bayer AG annual operating income
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Bayer AG Operating Income Growth & History (BAYN)
Bayer AG's operating income was −€1.08B for fiscal 2025.
View full Bayer AG company overviewBayer AG annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −€1.08B | −€1.01B | — |
| 2024 | 2024-12-31 | −€71.0M | −€683.0M | — |
| 2023 | 2023-12-31 | €612.0M | −€6.40B | −91.27% |
| 2022 | 2022-12-31 | €7.01B | €3.66B | +109.13% |
| 2021 | 2021-12-31 | €3.35B | €11.07B | — |
| 2020 | 2020-12-31 | −€7.72B | −€13.59B | — |
| 2019 | 2019-12-31 | €5.87B | €1.96B | +49.95% |
| 2018 | 2018-12-31 | €3.91B | −€6.83B | −63.59% |
| 2017 | 2017-12-31 | €10.75B | €3.49B | +48.02% |
| 2016 | 2016-12-31 | €7.26B | €935.0M | +14.78% |
| 2015 | 2015-12-31 | €6.33B | €821.0M | +14.91% |
| 2014 | 2014-12-31 | €5.51B | €572.0M | +11.59% |
| 2013 | 2013-12-31 | €4.93B | €974.0M | +24.60% |
| 2012 | 2012-12-31 | €3.96B | −€189.0M | −4.56% |
| 2011 | 2011-12-31 | €4.15B | €1.93B | +86.89% |
| 2010 | 2010-12-31 | €2.22B | — | — |
Bayer AG quarterly operating income
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €827.0M | €814.0M | +6261.54% |
| Q1 2026 | 2026-03-31 | €3.53B | — | — |
| Q4 2025 | 2025-12-31 | €4.34B | — | — |
| Q3 2025 | 2025-09-30 | −€543.0M | — | — |
| Q2 2025 | 2025-06-30 | €13.0M | — | — |
Bayer AG operating income trends
Over the last five fiscal years, Bayer AG's operating income increased from −€7.72B to −€1.08B, a change of €6.64B. The latest reported quarter, Q2 2026, shows €827.0M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
reported operating income
TickerStat standardizes operating income reported in company official filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bayer AG source filings ↗Community posts
Bayer wins the first Roundup trial following the Supreme Court ruling
A Missouri jury unanimously ruled for Bayer ($BAYN)’s Monsanto unit in a three-plaintiff Roundup case, rejecting design-defect, fraud and negligence claims. It was the first such trial following the US Supreme Court decision that blocked th ...
Bayer’s Nubeqa cuts risk of metastasis or death in prostate trial
Bayer ($BAYN) disclosed interim Phase 3 results showing that adding Nubeqa to hormone therapy and radiation reduced the risk of metastasis or death by 58% in prostate-cancer patients at high risk of recurrence. Four-year metastasis-free sur ...
